142 related articles for article (PubMed ID: 27250888)
1. Expression of VEGF-A in Epithelial Ovarian Cancer: Correlation with Morphologic Types, Grade and Clinical Stage.
Premalata CS; Umadevi K; Shobha K; Anurekha M; Krishnamoorthy L
Gulf J Oncolog; 2016 May; 1(21):49-54. PubMed ID: 27250888
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.
Bhaskari J; Premalata CS; Shilpa V; Rahul B; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2016 Jan; 37(1):1017-23. PubMed ID: 26264619
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer.
Oktem G; Sanci M; Bilir A; Yildirim Y; Kececi SD; Ayla S; Inan S
Int J Gynecol Cancer; 2012 Jan; 22(1):23-9. PubMed ID: 22080880
[TBL] [Abstract][Full Text] [Related]
4. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer.
Siddiqui GK; Maclean AB; Elmasry K; Wong te Fong A; Morris RW; Rashid M; Begent RH; Boxer GM
Angiogenesis; 2011 May; 14(2):155-61. PubMed ID: 21221762
[TBL] [Abstract][Full Text] [Related]
6. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
7. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
Szubert S; Szpurek D; Moszynski R; Nowicki M; Frankowski A; Sajdak S; Michalak S
J Cancer Res Clin Oncol; 2014 Mar; 140(3):361-9. PubMed ID: 24374756
[TBL] [Abstract][Full Text] [Related]
9. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer.
Shen W; Li HL; Liu L; Cheng JX
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer.
Chen Y; Zhang L; Pan Y; Ren X; Hao Q
Int J Mol Sci; 2012 Oct; 13(10):13264-74. PubMed ID: 23202951
[TBL] [Abstract][Full Text] [Related]
11. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
Sun LX; Wu Y; Han HQ; Wang QH
Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.
Ye F; Hu Y; Zhou C; Hu Y; Chen H
Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
[TBL] [Abstract][Full Text] [Related]
15. Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis.
He L; He J; Zhao X
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e161-6. PubMed ID: 23915006
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer.
Fu Y; Lai Y; Wang Q; Liu X; He W; Zhang H; Fan C; Yang G
Mol Med Rep; 2013 Jun; 7(6):1726-32. PubMed ID: 23616046
[TBL] [Abstract][Full Text] [Related]
17. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
18. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer.
Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G
Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380
[TBL] [Abstract][Full Text] [Related]
19. Emerging Role of Nestin as an Angiogenesis and Cancer Stem Cell Marker in Epithelial Ovarian Cancer: Immunohistochemical Study.
Osman WM; Shash LS; Ahmed NS
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):571-580. PubMed ID: 26945442
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.
Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M
Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]